429 related articles for article (PubMed ID: 28705934)
1. G
Badolia R; Inamdar V; Manne BK; Dangelmaier C; Eble JA; Kunapuli SP
J Biol Chem; 2017 Sep; 292(35):14516-14531. PubMed ID: 28705934
[TBL] [Abstract][Full Text] [Related]
2. Akt and mitogen-activated protein kinase enhance C-type lectin-like receptor 2-mediated platelet activation by inhibition of glycogen synthase kinase 3α/β.
Moroi AJ; Watson SP
J Thromb Haemost; 2015 Jun; 13(6):1139-50. PubMed ID: 25858425
[TBL] [Abstract][Full Text] [Related]
3. A novel Syk-dependent mechanism of platelet activation by the C-type lectin receptor CLEC-2.
Suzuki-Inoue K; Fuller GL; García A; Eble JA; Pöhlmann S; Inoue O; Gartner TK; Hughan SC; Pearce AC; Laing GD; Theakston RD; Schweighoffer E; Zitzmann N; Morita T; Tybulewicz VL; Ozaki Y; Watson SP
Blood; 2006 Jan; 107(2):542-9. PubMed ID: 16174766
[TBL] [Abstract][Full Text] [Related]
4. A Comprehensive Tyrosine Phosphoproteomic Analysis Reveals Novel Components of the Platelet CLEC-2 Signaling Cascade.
Izquierdo I; Barrachina MN; Hermida-Nogueira L; Casas V; Morán LA; Lacerenza S; Pinto-Llorente R; Eble JA; de Los Ríos V; Domínguez E; Loza MI; Casal JI; Carrascal M; Abián J; García A
Thromb Haemost; 2020 Feb; 120(2):262-276. PubMed ID: 31901221
[TBL] [Abstract][Full Text] [Related]
5. Syk-dependent phosphorylation of CLEC-2: a novel mechanism of hem-immunoreceptor tyrosine-based activation motif signaling.
Séverin S; Pollitt AY; Navarro-Nuñez L; Nash CA; Mourão-Sá D; Eble JA; Senis YA; Watson SP
J Biol Chem; 2011 Feb; 286(6):4107-16. PubMed ID: 21098033
[TBL] [Abstract][Full Text] [Related]
6. Characterization of UBO-QIC as a Gαq inhibitor in platelets.
Inamdar V; Patel A; Manne BK; Dangelmaier C; Kunapuli SP
Platelets; 2015; 26(8):771-8. PubMed ID: 25734215
[TBL] [Abstract][Full Text] [Related]
7. C-type lectin-like receptor-2 (CLEC-2) is a key regulator of kappa-carrageenan-induced tail thrombosis model in mice.
Yokomori R; Shirai T; Tsukiji N; Oishi S; Sasaki T; Takano K; Suzuki-Inoue K
Platelets; 2023 Dec; 34(1):2281941. PubMed ID: 38010137
[TBL] [Abstract][Full Text] [Related]
8. Relative contribution of G-protein-coupled pathways to protease-activated receptor-mediated Akt phosphorylation in platelets.
Kim S; Jin J; Kunapuli SP
Blood; 2006 Feb; 107(3):947-54. PubMed ID: 16223779
[TBL] [Abstract][Full Text] [Related]
9. Botrocetin/VWF-induced signaling through GPIb-IX-V produces TxA2 in an alphaIIbbeta3- and aggregation-independent manner.
Liu J; Pestina TI; Berndt MC; Jackson CW; Gartner TK
Blood; 2005 Oct; 106(8):2750-6. PubMed ID: 15985541
[TBL] [Abstract][Full Text] [Related]
10. The novel Syk inhibitor R406 reveals mechanistic differences in the initiation of GPVI and CLEC-2 signaling in platelets.
Spalton JC; Mori J; Pollitt AY; Hughes CE; Eble JA; Watson SP
J Thromb Haemost; 2009 Jul; 7(7):1192-9. PubMed ID: 19422460
[TBL] [Abstract][Full Text] [Related]
11. Distinct pathways regulate Syk protein activation downstream of immune tyrosine activation motif (ITAM) and hemITAM receptors in platelets.
Manne BK; Badolia R; Dangelmaier C; Eble JA; Ellmeier W; Kahn M; Kunapuli SP
J Biol Chem; 2015 May; 290(18):11557-68. PubMed ID: 25767114
[TBL] [Abstract][Full Text] [Related]
12. Significant Hypo-Responsiveness to GPVI and CLEC-2 Agonists in Pre-Term and Full-Term Neonatal Platelets and following Immune Thrombocytopenia.
Hardy AT; Palma-Barqueros V; Watson SK; Malcor JD; Eble JA; Gardiner EE; Blanco JE; Guijarro-Campillo R; Delgado JL; Lozano ML; Teruel-Montoya R; Vicente V; Watson SP; Rivera J; Ferrer-Marín F
Thromb Haemost; 2018 Jun; 118(6):1009-1020. PubMed ID: 29695020
[TBL] [Abstract][Full Text] [Related]
13. Tyrosine phosphorylation on spleen tyrosine kinase (Syk) is differentially regulated in human and murine platelets by protein kinase C isoforms.
Buitrago L; Bhavanasi D; Dangelmaier C; Manne BK; Badolia R; Borgognone A; Tsygankov AY; McKenzie SE; Kunapuli SP
J Biol Chem; 2013 Oct; 288(40):29160-9. PubMed ID: 23960082
[TBL] [Abstract][Full Text] [Related]
14. The toll-like receptor 2/1 (TLR2/1) complex initiates human platelet activation via the src/Syk/LAT/PLCγ2 signalling cascade.
Fälker K; Klarström-Engström K; Bengtsson T; Lindahl TL; Grenegård M
Cell Signal; 2014 Feb; 26(2):279-86. PubMed ID: 24240055
[TBL] [Abstract][Full Text] [Related]
15. A detailed proteomic analysis of rhodocytin-activated platelets reveals novel clues on the CLEC-2 signalosome: implications for CLEC-2 signaling regulation.
Parguiña AF; Alonso J; Rosa I; Vélez P; González-López MJ; Guitián E; Eble JA; Loza MI; García Á
Blood; 2012 Dec; 120(26):e117-26. PubMed ID: 23053573
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of Src but not Syk causes weak reversal of GPVI-mediated platelet aggregation measured by light transmission aggregometry.
Cheung HYF; Moran LA; Sickmann A; Heemskerk JWM; Garcia Á; Watson SP
Platelets; 2022 Nov; 33(8):1293-1300. PubMed ID: 35535424
[TBL] [Abstract][Full Text] [Related]
17. Dextran sulfate triggers platelet aggregation via direct activation of PEAR1.
Vandenbriele C; Sun Y; Criel M; Cludts K; Van Kerckhoven S; Izzi B; Vanassche T; Verhamme P; Hoylaerts MF
Platelets; 2016 Jun; 27(4):365-72. PubMed ID: 26619766
[TBL] [Abstract][Full Text] [Related]
18. Hematopoietic lineage cell-specific protein-1 (HS1) regulates PAR-mediated ERK activation and thromboxane generation in platelets.
Kahner BN; Dorsam RT; Kim S; Shankar H; Kitamura D; Kunapuli SP
Platelets; 2008 Dec; 19(8):614-23. PubMed ID: 19012179
[TBL] [Abstract][Full Text] [Related]
19. The novel platelet activation receptor CLEC-2.
Suzuki-Inoue K; Inoue O; Ozaki Y
Platelets; 2011; 22(5):380-4. PubMed ID: 21714702
[TBL] [Abstract][Full Text] [Related]
20. Negative regulation of Gq-mediated pathways in platelets by G(12/13) pathways through Fyn kinase.
Kim S; Kunapuli SP
J Biol Chem; 2011 Jul; 286(27):24170-9. PubMed ID: 21592972
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
